Partnership boosts private access to clinical trials
GenesisCare and the Trans-Tasman Radiation Oncology Group (TROG) have entered a strategic partnership that could provide private patients with increased access to clinical trials.
TROG, a non-profit organisation, is a global leader in radiotherapy research and has more than 50 clinical trials under way involving 12,000 patient volunteers.
The two organisations say the partnership will improve patient access to clinical trials and promote innovation in research.
The partnership increases TROG’s clinic base to around 85 sites.